No dramas at all Cortinaboy, I was wondering where you were with it. Given the stance with EMEA and FDA on the bronchiectasis front, I would seriously doubt the TGA on granting registration without the other planned Phase III study. Also, it is not as though our market will make it for this drug so I don't think the market would react poorly if the TGA held back till the other study is completed.
I think the Cystic Fibrosis results will be the most important driver in the short term. There should be a nice lead up in the SP prior to the results being released Q2 2009.
VVS
No dramas at all Cortinaboy, I was wondering where you were with...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 752779 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |